BSMA leadership conversations regarding COVID-19 crisis Som Chattopadhyay Amgen’s Vice President of Global Supply Chain, Som Chattopadhyay, has seen it all. Throughout these events, he reports, “Amgen has not faced any shortages. It’s every patient, every time.” The...
Clearly, supply chain has been one of the most impacted functions at all these life science firms. But BSMA leaders have demonstrated a willingness and ability to respond quickly and effectively. For example, many biopharmaceutical firms tap other groups for scenario...
Matt Yedwabnick, Senior Director, Supply Chain, Atara Biotherapeutics BSMA leadership on COVID-19 supply chain challenges April 7 2020 Atara Biotherapeutics is a clinical-stage company developing off-the-shelf, allogeneic T-cell immunotherapy. “From our standpoint,”...
According to Kevin Pegels, Vice President, Global Supply Chain, Illumina, during the COVID-19 pandemic, “Employee safety remains our #1 priority. Due to our role in making, testing, and shipping products used in healthcare, we are critical infrastructure delivering an...
Supply Chain Leader, Vice President, Global Supply Chain, Biopharmaceutical Company, April 8 2020 [Names prefer to remain anonymous] This leading Bay Area Biopharmaceutical Company has plugged into several benchmarking initiatives focused on COVID-19. One of these is...
Stefano Volonte leads North America and LatAm commercial supply chain for Roche/Genentech. During the COVID-19 pandemic, he commented on three areas: Supply chain resilience By design, Roche/Genentech had already established dual/multiple locations for several, key...